Calling all Life Science Students

Your Roadmap to Success Looking for ways to leverage your education and land a career in the life sciences industry? Then you must attend the DIA 2013 49th Annual Meeting. For only $250, you can network with more than 7,000 life sciences professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products to unlock the innovation needed to expand global access to effective and affordable patient care.. Get your name alongside top thought leaders, innovators, and experts all seeking fresh knowledge and sharpening their skills for the future. You must be registered by May 17  to make the Advance Attendee List which is distributed to all participants. Download Registration Form Eligibility Students must be an undergraduate or graduate student who can document that they are enrolled in a degree granting or certificate-granting academic program in an accredited academic institution, whose content is consistent with the mission of DIA for at least 12 undergraduate hours annually or 9 graduate hours annually.     4 Days. 22 Tracks. 250+ Educational Offerings. 450+ Exhibitors. 7,000+ Attendees. Student Forum “Getting a Job and Developing a Career” June 25 | 10:15-11:45AM ET This year’s forum will cover getting a job with presentations on soft skills, interviewing and using internships and fellowships to launch your career. An additional topic - finding a mentor - will introduce the theme of going from finding a job to developing a career. A good mentor can guide you with priceless tacit knowledge that otherwise could take years to find. Speakers: Soft Skills and Interviewing Kelleen Flaherty, MS, Assistant Professor, University of the Sciences in Philadelphia Using Fellowships and Internships to Start Your Career Justin Balint, PharmD, Post-Doctoral Fellow, Oncology Advocacy and Policy, Rutgers Finding a Mentor to Guide your Career Amy N. Grant, MS, Director, Global Regulatory Strategy & Science, ViroPharma Inc. Career Center The DIA Career Center is your go-to resource for careers in the life sciences industry. Use the Career Center to find your ideal job or internship today! Continuing Education Credits Earn CE credits for attending sessions, forums, workshops, symposia, and more Network!  Network!  Network! Receptions, Networking Lunches, Student & Professional Posters, Speed Networking Session View This Year's Student and Professional Posters Student Group Discounts Available! Register 10 from your university and receive the 11th FREE! Contact Donna Mayer at donna.mayer@diahome.org         for eligibility and registration details.

Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.

Your Tailored Agenda Covering Rare/Orphan Diseases for DIA 2013 49th Annual Meeting

Navigate Your Way to Success at the Largest Life Sciences Meeting in the Region We want to make your DIA 2013 49th Annual Meeting experience a breeze. Navigating through more than 250 educational offerings across 22 tracks can be overwhelming to select the sessions that best fit your needs. We have provided a tailored schedule for professionals involved with Rare/Orphan Diseases. We did the work for you! What’s more, bring your colleagues or your whole team - divide and conquer - with so many exceptional sessions, split the sessions and benefit from more at DIA 2013 49th Annual Meeting. Contact our Group Discount Representative for details! Don't miss out on this opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships with the greatest educational offerings under one roof.   Monday, June 24 European Town Hall: Implementation of New Safety Legislation and Other Hot Topics 11:00AM-12:30PM ET The focus of this forum will be on the first experiences with the new PRAC and how the PRAC interacts with the different EU committees (such as the CHMP and CMDh). Roundtable on Personalized Therapy Innovation in Rare Disease: Focus on Public Policy 2:30-4:00PM ET Orphan product developers face unique challenges that multiply when combined with the need for co-registered diagnostic devices. This forum will discuss the latest policy trends impacting personalized orphan products and patient access. Tuesday, June 25 Research Advances for Rare Diseases and Orphan Products 8:00-9:30AM ET In 2012, a third of the drugs approved by the FDA had orphan designation. This session will examine the current research efforts and discuss the role of the patient community, the FDA, the NIH and the drug industry in research priorities and challenges. Is There a Recipe for Successful Implementation of Registries for Rare Diseases? 1:45-3:15PM ET This session will describe how registries can support development of new drug for rare diseases, how they can contribute to regulatory approval, and decisions on access to orphan medicinal products. Roundtable on Personalized Therapy Innovation in Rare Disease: Focus on Public Policy 2:30-4:00PM ET Orphan product developers face unique challenges that multiply when combined with the need for co-registered diagnostic devices. This forum will discuss the latest policy trends impacting personalized orphan products and patient access. Development for Rare Disease Treatments 4:00-5:30PM ET This symposium will review various aspects of therapy development for rare and orphan diseases. The difficulties and trade-offs in developing a comprehensive patient registry to assess natural disease progression and treatment effects will be highlighted using pemphigoid as a case example. Wednesday, June 26 Models for Genomic Research Success: How a Patient-Researcher Relationship Led to the Discovery of a Norepinephrine Transporter Deficiency and the Emerging Role of Crowd Sourcing in Rare Disease Research 8:00-9:30AM ET Get a review of successful genomic studies that have been driven by strong patient-investigator relationships, and the recent role of social media and crowd sourcing in rare disease studies. Using Legislation to Advance Regulatory Science: "I'm Just a Bill..." 8:00-9:30AM ET Several legislations have been introduced for regulatory reform of the drug approval process. This session will discuss impacts on the pharmaceutical industry, investment community, and patient community. Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market 1:45-3:15PM ET One in ten people could be affected by a rare disease; for many there is no treatment, yet modern technology could resolve this. This session investigates the opportunities available to facilitate successful global development of novel orphan medicines. Rescuing and Repurposing Drugs: Challenges and Opportunities 4:00-5:30PM ET Drug rescue and repurposing presents an opportunity to spur the drug development process by building upon previous research and development efforts. However, this strategy also has challenges, particularly related to treatments for rare and orphan diseases. Thursday, June 27 The Not So Rare Challenge that Faces Rare Disease Development: Demonstrate Value 9:00-10:30AM ET Increased development of orphan products has changed how payer regulators view rare diseases. Rare disorders can now have several products FDA indicated for use; this requires that developers demonstrate the value of these rare disease products. Orphan Drug Development Strategy by Big and Medium/Small Pharmaceutical Industries 9:00-10:30AM ET This session will address considerations for planning the development and commercialization strategy of orphan drugs by large as well as small companies. Sunday, June 23 Preconference Tutorials Kick off the week by extending your education prior to the start of the Annual Meeting. Register for two half-day tutorials or one full-day tutorial and SAVE $100 on of your Annual Meeting registration. View Preconference Tutorials ‘Class of 2013’ Patient Advocate Fellowship Program      • African-American Community Health Group        of the Central Coast      • AIM at Melanoma      • American Cancer Society Cancer Action        Network      • Angioma Alliance      • Ann's Place: the Home of I CAN      • Coalition for Pulmonary Fibrosis      • Dystonia Medical Research Foundation      • Hepatitis Education Project      • Hermansky-Pudlak Syndrome Network      • Leukemia & Lymphoma Society - Mass Chapter • Lymphatic Research Foundation • MitoAction • National Foundation for Celiac Awareness • NephCure Foundation • PMP Pals • Program in Personalized Medicine & Targeted   Therapeutics • Recurrent Respiratory Papillomatosis    Foundation • Spinal Muscular Atrophy Foundation • The Michael J Fox Foundation for Parkinson's     Research Keynote Speaker Hotel & Travel Exhibiting     Daniel Kraft, MD Executive Director, FutureMed Book within the DIA Room Block, get special perks! 90% of the hall is SOLD. Reserve your booth today!

Email Preferences    |    My DIA    |    Forward to a Friend    |

Sign up today to have the latest news in drug development worldwide delivered to your inbox ~ DIA's Global Smartbrief.

Report: Twin Cities Area Continues To Be A Medical Device Hot Spot.

Sign up today to have the latest news in drug development worldwide delivered to your inbox ~ DIA's Global Smartbrief

From Minnesota, the Minneapolis Star Tribune (4/10, Moore) reports that "the Twin Cities' cluster of medical device and life-sciences companies slipped a notch in 2012, but the area continues its stronghold as a medical device hot spot, according a recently released report." The report, put together by the firm Jones Lang LaSalle, did not specify why Minneapolis-St. Paul went from eighth to ninth place. Instead, it measured "employment in high-tech research and in the hospital/medical fields, the number of life sciences establishments, and the prevalence of National Institutes of Health (NIH) and venture capital funding." The Star Tribune points out that biotechnology and pharmaceutical companies are considered under the life-sciences category in the report, as well as medical device companies. While the Twin Cities has the latter (Medtronic, St. Jude Medical), it lacks the former.

DIA Daily. This daily enewsletter features summaries of breaking news and information about the pharmaceutical, biotechnology, and medical device fields from thousands of global news sources. This easy-to-read enewsletter is delivered to your inbox every business morning.

Subscribe to the DIA Daily.View archives.
iPhone and iPad Apps available! Download "BulletinHC."DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.

If you would like more information about, or have a question pertaining to, DIA Membership and its benefits, please email membership@diahome.org.Click here to check your membership status.

Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044 Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191

Navigate Your Way to Success at the Largest Life Sciences Meeting in the Region - DIA2013

Navigate Your Way to Success at the Largest Life Sciences Meeting in the Region We want to make your DIA 2013 49th Annual Meeting experience a breeze. Navigating through more than 250 educational offerings across 22 tracks can be overwhelming to select the sessions that best fit your needs. We have provided a tailored schedule for Clinical Safety and Pharmacovigilance Professionals. We did the work for you! What’s more, bring your colleagues or your whole team - divide and conquer - with so many exceptional sessions, spilt the sessions and benefit from more at DIA 2013 49th Annual Meeting. Contact our Group Discount Representative for details! Don't miss out on this opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships with the greatest educational offerings under one roof. Lead the Way to Expedite Products to Market! Monday, June 24 Electronic Health Records (EHRs) in Signal Detection and Evaluation 11:00AM-12:30PM ET This session will provide and in-depth update on various initiatives that have been launched worldwide to investigate the uses of electronic health records (EHRs). Narrative Medicine and Pharmacovigilance 11:00AM-12:30PM ET In recent years, pharmacovigilance has emphasized the collection and submission of tabular data. Using ideas from narrative medicine, we can re-focus on the patient’s story to better understand adverse drug reactions and Benefit-risk balance. European Town Hall: Implementation of New Safety Legislation and Other Hot Topics 11:00AM-12:30PM ET Get the first experiences with the new PRAC and how the PRAC interacts with the different EU committees (such as the CHMP and CMDh). The New Standards for the Identification of Medicinal Products and Individual Case Safety Reporting Applied in Pharmacovigilance 2:30-4:00PM ET The development of the international standards arising from the International Conference on Harmonization (ICH) are close to finalization and implementation. Hear about the status of the two related projects from an EMA and FDA perspective and the industry response to this work. Characterizing Drug Shortages and Their Causes: Anticipating Future Trends 2:30-4:00PM ET This session includes information on a 2012 study highlighting where and why drug shortages occur, as well as the impact of other forecasted drug development and commercialization trends. Tuesday, June 25 Aligning Statistical Science and Regulatory Practices for Expedited Safety Reporting 8:00-9:30AM ET Recommendations are presented from projects of the CTTI exploring expedited safety reporting for clinical trials, and aligning regulatory practices for reporting with statistics and patient expectations. Social Media, Mobile Applications and Patient Support Programs: Challenges and Solutions for Handling Drug Safety Information 8:00-9:30AM ET Discuss pharmacovigilance implications including adverse event handling and risk mitigation solutions from the regulatory and drug safety point of view. Big Data: Impact on Innovation 10:15-11:45AM ET Examine pharma, safety, and patient perspectives on big data and the need for real-world examples. EU Update: PROTECT and EnCePP 10:15-11:45AM ET Learn about PROTECT, which aims to develop and validate innovative methods for Benefit-risk assessment of medicine Periodic Reporting in Drug Safety: From Safety Updates to Continuous Signal Monitoring and Benefit-Risk Evaluations 1:45-3:15PM ET The session will present the new structure of PSURs/PBRERs according to the GVP/ICH E2C(R2) guidance. Requirements and challenges will be outlined. Quality Assurance for Signal Detection Programs 1:45-3:15PM ET New EU legislation requires quality assurance of critical safety processes, including signal detection. This forum will discuss the best practices for a signal detection program. Risk Management in the US, EU and Japan: The Challenges of Diversity 4:00-5:30PM ET This interactive forum will discuss the differences in legislation and the challenges of risk management planning in the United States, Europe, and Japan. Wednesday, June 26 Molecular Predictors of Drug-induced Harm: From Clinical Development to Postmarketing Surveillance 8:00-9:30AM ET This session will describe opportunities to identify molecular predictors of drug-induced harm in clinical development and postmarketing surveillance. Pharmacovigilance Update for Japan, Developing Asia and Latin America 8:00-9:30AM ET Review the current status of pharmacovigilance and provide suggestions on how to meet reporting requirements and working with licensing partners and affiliated companies in Japan and the developing world in Asia and Latin America. An Interactive Course on Likelihood Ratio Test-based Method for Signal Detection 1:45-3:15PM ET This workshop will provide an overview of the likelihood ratio test-based signal detection method for FDA’s AERS database, as well as a demonstration of the (LRT) tool. TransCelerate’s Collaborative Approach to Risk-based Monitoring: The Methodology 1:45-3:15PM ET Learn about the methodology developed by TransCelerate members for quality risk management and risk-based monitoring implementation. Herbal-induced Organ Toxicity (HILI): How That May Impact Rx Benefit-risk 4:00-5:30PM ET Discuss the role of natural health products in risk assessment and the importance of the internal review process. Developing a Patient Aid to Make Information about Treatment Benefits, Harms and Uncertainties Meaningful to Individual Patients and Enhance Their Decisions 4:00-5:30PM ET The session will: 1) raise awareness across the decision-making health community about recent drug regulatory science innovations driving a patient-focused approach; and 2) be a springboard to trigger further engineering of applications for these trends for use across the community. Thursday, June 27 Tracking Misuse and Abuse of Marketed Products: Is Pharma Doing All that It Can? 9:00-10:30AM ET This session will focus on the best practices involved in monitoring, tracking and reporting off-label use and misuse and abuse of pharmaceutical products. Coding with Confidence 9:00-10:30AM ET You will apply the key principles of the “MedDRA® Term Selection: Points to Consider” document by engaging in practical coding exercises in an interactive format. Off-target Blood Pressure Changes and Evaluation in Drug Development: Safety,Clinical and Regulatory Considerations 10:45-12:45AM ET Gain insight into the “off-target” BP response of drugs outside of cardiovascular drugs from a development and regulatory perspective. Sunday, June 23 Preconference Tutorials Kick off the week by extending your education prior to the start of the Annual Meeting. Register for two half-day tutorials or one full-day tutorial and SAVE $100 on of your Annual Meeting registration. Risk Communications 9:00AM-5:00PM ET Analysis of Safety Data from Clinical Trials 1:00-4:30PM ET Highlights of the New Pharmacovigilance Legislation in the EU: Key Points to be Taken into Account for Successful Implementation and Lessons Learned 1:00-4:30PM ET Keynote Speaker Hotel & Travel Exhibiting Daniel Kraft, MD Executive Director, FutureMed Book within the DIA Room Block, get special perks! 90% of the hall is SOLD. Reserve your booth today!

Email Preferences | My DIA | Forward to a Friend |

Showcase Your Products to DIA’s Highly Influential Global Community of Life Science Professionals

Showcase Your Products to DIA’s Highly Influential Global Community of Life Science Professionals Did you know DIA holds numerous meetings, workshops, and conferences around the world that bring together the most influential players in the life science industry? Attendance for these events range from 50 to 7,500 attendees, most venues offer exhibiting and advertising opportunities for nearly every budget.   Reach global decision makers at one of DIA’s upcoming events:  Pharmacovigilance and Risk Management Strategies 2013 January 14-16 | Washington, DC Marketing Pharmaceuticals 2013 February 20-21 | Washington, DC Medical and Scientific Communications 2013 Annual Forum March 19-21 | Chandler, AZ CMC Workshop 2013 April 15-17 | Washington, DC DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science June 24-26 | Boston, MA “Ten of our top clients have signed on with us as a result of our exhibiting at DIA.” Innovative Print and Media Group, Inc. “Exhibiting at DIA is an important marketing component for anyone working in this space.” Trifecta Multimedical For more information about exhibiting, contact Shannon Lewis or Jeff Korn.